dures or even the need to leave home. In a study of 99 patients with unexplained infertility who qualified for IVF treatment, six months use of DuoFertility was shown to be as effective in achieving pregnancy as one cycle of IVF.
(To read the full academic paper, please visit: http://www.duofertility.com/duofertility-vs-ivf
.) In addition to pinpointing ovulation, the data DuoFertility generates can be also be used to detect a range of medical conditions. In these cases, a report is generated for the couple's doctor that summarises the results and recommends potential courses of action.
DuoFertility is available in the United Kingdom for 495 pounds Sterling (approximately US$800), which is roughly one-tenth of the cost of a typical cycle of IVF. CTC is so confident in the efficacy of their product that DuoFertility comes with a "pregnant in one year or your money back" guarantee, giving customers total reassurance in choosing this new breakthrough technology.
Don Jones, Vice President, Wireless Health, Global Strategy and Market Development, Qualcomm Labs and Chairman of the WLSA, said, "Cambridge Temperature Concepts is representative of everything we look for in an I Award winner – a powerful convergence of wireless and healthcare technologies that both reduces cost and improves patient outcomes. Their DuoFertility product offers a low cost, non-invasive and convenient alternative to IVF and other invasive fertility therapies for the many couples who experience unexplained infertility and we're delighted to recognise this important step forward in wireless health."
Dr. Shamus Husheer, CEO and co-founder of Cambridge Temperature Concepts, said, "We founded our company because we saw that wireless sensing technology had the potential to help millions of infertile couples and so we are especially ple
Page: 1 2 3 4 Related medicine technology :1
|SOURCE Cambridge Temperature Concepts|
Copyright©2010 PR Newswire.
All rights reserved
. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences2
. Caliper Life Sciences to Acquire Cambridge Research & Instrumentation3
. Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP Obtain Three Defense Verdicts for I-Flow in Oregon Infusion Pump Cases4
. Novartis to Expand Global Research Headquarters in Cambridge, MA5
. NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts6
. Cambridge Scientists Archive 500,000th Crystal Structure7
. Cambridge-based Ligon Discovery Raises $1M in Seed Funding8
. Cambridge Laboratories Announces Approval of Tetrabenazine in Spain9
. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters10
. Facebook Page on Low Body Temperature Offers Free Coupon Codes to Fans11
. Global Temperature Monitoring Devices Industry